Potato-Based Supplement for Bone Marrow Transplant Patients
Trial Summary
What is the purpose of this trial?
This trial is testing a potato-based resistant starch supplement for patients receiving stem cell transplants. The goal is to see if this supplement can safely and effectively reduce a common complication called acute GVHD by boosting a helpful substance in the gut.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the potato-based supplement safe for humans?
A study with bone marrow transplant patients showed that resistant potato starch was feasible to use, and it increased beneficial gut compounds without reporting any safety issues. However, long-term use in animals showed mixed effects on gut health, suggesting both positive and negative impacts.12345
How is the potato-based supplement treatment different from other treatments for bone marrow transplant patients?
The potato-based supplement, Bob's Red Mill®, is unique because it uses resistant potato starch, which may help improve gut health and nutrition in bone marrow transplant patients, unlike traditional treatments that often rely on parenteral nutrition (feeding through a vein) with higher infection risks.678910
Research Team
Mary Riwes, DO
Principal Investigator
University of Michigan Rogel Cancer Center
Eligibility Criteria
This trial is for individuals over 18 years old (or over 10 and weighing at least 50 kg in phase II) who are undergoing matched related full intensity allogeneic stem cell transplantation. They must have a good performance status, be able to swallow pills, and sign informed consent. Excluded are those with active Clostridium difficile infection, enrolled in other GVHD prevention trials, or with conditions like inflammatory bowel disease.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Conditioning
Participants begin dietary supplement with potato-based resistant starch prior to conditioning phase
Treatment
Participants receive dietary supplement from day -7 to day +100 to mitigate GVHD
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Bob's Red Mill® (Resistant Starch)
- Starch Placebo (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
Marschall S. Runge
University of Michigan Rogel Cancer Center
Chief Executive Officer since 2015
MD, PhD
Eric R. Fearon
University of Michigan Rogel Cancer Center
Chief Medical Officer since 2016
MD, PhD